| 1 |
国家卫生健康委办公厅，国家中医药局综合司. 关于印发新型冠状病毒感染诊疗方案(试行第十版)的通知[EB/OL]．(2023-01-06)[2023-01-07].
URL
|
| 2 |
Kostopanagiotou K, Schuurmans MM, Inci I, et al. COVID-19-related end stage lung disease: two distinct phenotypes[J]. Ann Med, 2022, 54(1)：588-590.
|
| 3 |
ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, et al. Acute respiratory distress syndrome: the Berlin definition[J]. JAMA, 2012, 307(23)：2526-2533.
|
| 4 |
Pu D, Zhai X, Zhou Y, et al. A narrative review of COVID-19-related acute respiratory distress syndrome (CARDS): "typical" or "atypical" ARDS？[J]. Ann Transl Med, 2022, 10(16)：908.
|
| 5 |
Montenegro F, Unigarro L, Paredes G, et al. Acute respiratory distress syndrome (ARDS) caused by the novel coronavirus disease (COVID-19): a practical comprehensive literature review[J]. Expert Rev Respir Med, 2021, 15(2)：183-195.
|
| 6 |
Mazzolini M, Monari M, Angeletti G, et al. Fatal pulmonary fibrosis complicating COVID-19 infection in preexistent emphysema[J]. Radiol Case Rep, 2021, 16(2)：361-363.
|
| 7 |
Han X, Fan Y, Alwalid O, et al. Fibrotic interstitial lung abnormalities at 1-year follow-up CT after severe COVID-19[J]. Radiology, 2021, 301(3)：E438-E440.
|
| 8 |
Chen JY, Qiao K, Liu F, et al. Lung transplantation as therapeutic option in acute respiratory distress syndrome for coronavirus disease 2019-related pulmonary fibrosis[J]. Chin Med J (Engl), 2020, 133(12)：1390-1396.
|
| 9 |
Roach A, Chikwe J, Catarino P, et al. Lung transplantation for Covid-19-related respiratory failure in the United States[J]. N Engl J Med, 2022, 386(12)：1187-1188.
|
| 10 |
King CS, Mannem H, Kukreja J, et al. Lung transplantation for patients with COVID-19[J]. Chest, 2022, 161(1)：169-178.
|
| 11 |
Kurihara C, Manerikar A, Querrey M, et al. Clinical characteristics and outcomes of patients with COVID-19-associated acute respiratory distress syndrome who underwent lung transplant[J]. JAMA, 2022, 327(7)：652.
|
| 12 |
中华医学会器官移植学分会. 中国肺移植受者选择与术前评估技术规范(2019版) [J/CD]. 中华移植杂志：电子版，2019, 13(2)：81-86.
|
| 13 |
Badulak J, Antonini MV, Stead CM, et al. Extracorporeal membrane oxygenation for COVID-19: updated 2021 guidelines from the Extracorporeal Life Support Organization[J]. ASAIO J, 2021, 67(5)：485-495.
|
| 14 |
Cilli A, Hanta I, Uzer F, et al. Characteristics and outcomes of COVID-19 patients with IPF: a multi-center retrospective study[J]. Respir Med Res, 2022, 81：100900.
|
| 15 |
Sheikh D, Tripathi N, Chandler TR, et al. Clinical outcomes in patients with COPD hospitalized with SARS-CoV-2 versus non-SARS-CoV-2 community-acquired pneumonia[J]. Respir Med, 2022, 191：106714.
|